annual EBIT:
-$279.00M+$20.00M(+6.69%)Summary
- As of today (September 16, 2025), RCUS annual earnings before interest & taxes is -$279.00 million, with the most recent change of +$20.00 million (+6.69%) on December 31, 2024.
- During the last 3 years, RCUS annual EBIT has fallen by -$334.00 million (-607.27%).
- RCUS annual EBIT is now -607.27% below its all-time high of $55.00 million, reached on December 31, 2021.
Performance
RCUS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$2.00M+$113.00M(+101.80%)Summary
- As of today (September 16, 2025), RCUS quarterly earnings before interest & taxes is $2.00 million, with the most recent change of +$113.00 million (+101.80%) on June 30, 2025.
- Over the past year, RCUS quarterly EBIT has increased by +$95.00 million (+102.15%).
- RCUS quarterly EBIT is now -99.29% below its all-time high of $281.54 million, reached on December 31, 2021.
Performance
RCUS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$292.00M+$95.00M(+24.55%)Summary
- As of today (September 16, 2025), RCUS TTM earnings before interest & taxes is -$292.00 million, with the most recent change of +$95.00 million (+24.55%) on June 30, 2025.
- Over the past year, RCUS TTM EBIT has dropped by -$48.00 million (-19.67%).
- RCUS TTM EBIT is now -449.54% below its all-time high of $83.54 million, reached on September 30, 2022.
Performance
RCUS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
RCUS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | +102.2% | -19.7% |
| 3 y3 years | -607.3% | +103.0% | -513.8% |
| 5 y5 years | -229.4% | +104.4% | -164.1% |
RCUS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -607.3% | +6.7% | at high | +101.8% | -449.5% | +24.6% |
| 5 y | 5-year | -607.3% | +6.7% | -99.3% | +101.8% | -449.5% | +24.6% |
| alltime | all time | -607.3% | +6.7% | -99.3% | +101.8% | -449.5% | +24.6% |
RCUS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.00M(-101.8%) | -$292.00M(-24.5%) |
| Mar 2025 | - | -$111.00M(+20.7%) | -$387.00M(+38.7%) |
| Dec 2024 | -$279.00M(-6.7%) | -$92.00M(+1.1%) | -$279.00M(+4.5%) |
| Sep 2024 | - | -$91.00M(-2.2%) | -$267.00M(+9.4%) |
| Jun 2024 | - | -$93.00M(+3000.0%) | -$244.00M(+8.4%) |
| Mar 2024 | - | -$3.00M(-96.3%) | -$225.00M(-24.7%) |
| Dec 2023 | -$299.00M(+13.3%) | -$80.00M(+17.6%) | -$299.00M(+4.9%) |
| Sep 2023 | - | -$68.00M(-8.1%) | -$285.00M(+1.1%) |
| Jun 2023 | - | -$74.00M(-3.9%) | -$282.00M(+2.9%) |
| Mar 2023 | - | -$77.00M(+16.7%) | -$274.00M(+3.8%) |
| Dec 2022 | -$264.00M(-580.0%) | -$66.00M(+1.5%) | -$264.00M(-416.0%) |
| Sep 2022 | - | -$65.00M(-1.5%) | $83.54M(+18.4%) |
| Jun 2022 | - | -$66.00M(-1.5%) | $70.56M(+16.5%) |
| Mar 2022 | - | -$67.00M(-123.8%) | $60.59M(+10.2%) |
| Dec 2021 | $55.00M | $281.54M(-461.1%) | $55.00M(-119.8%) |
| Sep 2021 | - | -$77.97M(+2.6%) | -$277.31M(+40.2%) |
| Jun 2021 | - | -$75.97M(+4.7%) | -$197.79M(+18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$72.59M(+43.0%) | -$167.19M(+35.9%) |
| Dec 2020 | -$123.00M(+45.2%) | -$50.78M(-3371.7%) | -$123.00M(+43.4%) |
| Sep 2020 | - | $1.55M(-103.4%) | -$85.75M(-22.4%) |
| Jun 2020 | - | -$45.38M(+59.8%) | -$110.55M(+17.2%) |
| Mar 2020 | - | -$28.40M(+109.9%) | -$94.34M(+11.4%) |
| Dec 2019 | -$84.71M(+54.4%) | -$13.53M(-41.8%) | -$84.71M(+0.1%) |
| Sep 2019 | - | -$23.25M(-20.3%) | -$84.67M(+15.1%) |
| Jun 2019 | - | -$29.16M(+55.3%) | -$73.56M(+22.0%) |
| Mar 2019 | - | -$18.77M(+39.2%) | -$60.30M(+9.9%) |
| Dec 2018 | -$54.86M(+2.7%) | -$13.48M(+11.0%) | -$54.86M(+0.3%) |
| Sep 2018 | - | -$12.14M(-23.6%) | -$54.72M(-16.7%) |
| Jun 2018 | - | -$15.90M(+19.3%) | -$65.71M(+10.5%) |
| Mar 2018 | - | -$13.33M(-0.1%) | -$59.47M(+11.3%) |
| Dec 2017 | -$53.44M(+193.9%) | -$13.34M(-42.3%) | -$53.44M(+33.3%) |
| Sep 2017 | - | -$23.13M(+139.4%) | -$40.10M(+136.4%) |
| Jun 2017 | - | -$9.66M(+32.4%) | -$16.96M(+132.4%) |
| Mar 2017 | - | -$7.30M | -$7.30M |
| Dec 2016 | -$18.18M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual EBIT year-on-year change?
- What is Arcus Biosciences, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly EBIT year-on-year change?
- What is Arcus Biosciences, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM EBIT year-on-year change?
What is Arcus Biosciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of RCUS is -$279.00M
What is the all time high annual EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual earnings before interest & taxes is $55.00M
What is Arcus Biosciences, Inc. annual EBIT year-on-year change?
Over the past year, RCUS annual earnings before interest & taxes has changed by +$20.00M (+6.69%)
What is Arcus Biosciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of RCUS is $2.00M
What is the all time high quarterly EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly earnings before interest & taxes is $281.54M
What is Arcus Biosciences, Inc. quarterly EBIT year-on-year change?
Over the past year, RCUS quarterly earnings before interest & taxes has changed by +$95.00M (+102.15%)
What is Arcus Biosciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of RCUS is -$292.00M
What is the all time high TTM EBIT for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM earnings before interest & taxes is $83.54M
What is Arcus Biosciences, Inc. TTM EBIT year-on-year change?
Over the past year, RCUS TTM earnings before interest & taxes has changed by -$48.00M (-19.67%)